z-logo
open-access-imgOpen Access
S710 Efficacy of High Dose Tofacitinib in Refractory Ulcerative Colitis Patients
Author(s) -
Usman S. Ansari,
Bincy Abraham
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776372.07239.37
Subject(s) - tofacitinib , medicine , ulcerative colitis , janus kinase inhibitor , infliximab , adverse effect , dosing , gastroenterology , refractory (planetary science) , vedolizumab , surgery , rheumatoid arthritis , disease , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here